Second-Generation LMA for Obesity
Trial Summary
What is the purpose of this trial?
This prospective, randomized, comparative study is intended to enroll a total of 148 patients with a BMI 30-49.9 kg/m2 undergoing surgery at Parkland Hospital. The efficacy and performance of a second-generation LMA will be compared to endotracheal intubation. A standardized anesthetic protocol that is usual and customary for the type of operation the patient is having will be provided to the anesthesia teams of enrolled subjects. The remainder of the anesthetic care of the subject will not deviate from the standard of care.
Research Team
Tiffany S Moon, M.D.
Principal Investigator
University of Texas
Eligibility Criteria
This trial is for adults aged 18-80 with obesity (BMI between 30 and 49.9) who are scheduled for non-emergency surgeries requiring general anesthesia. Participants must be able to consent in English or Spanish, not have severe lung or heart disease, and not be pregnant or nursing.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Anesthesia
Participants undergo surgery with either a second-generation LMA or endotracheal tube, following a standardized anesthetic protocol
Postoperative Monitoring
Participants are monitored for postoperative hypoxia and other vital signs in the PACU
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Endotracheal Intubation
- Second-Generation Laryngeal Mask Airway
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
M.D. Anderson Cancer Center
Collaborator